Preliminary clinical data for glioblastoma multiforme patients enrolled in a Phase 1 clinical trial demonstrated that 92 percent of evaluable patients treated with INB-200 exceeded a median ...

Glioblastoma multiforme (GBM), or simply glioblastoma, is a highly aggressive type of cancer that starts in your brain or spinal cord. It tends to spread quickly, and people with GBM often have poor ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted orphan drug designation to WP1122 for the treatment of glioblastoma multiforme, according to a ...

Gleolan, a dye used for brain imaging, can help surgeons visualize tumor tissue during surgery for glioblastoma multiforme. Malignant transformation occurs from aggregation of genetic alterations and ...

Glioblastoma is a cancerous growth in the brain. Treatment for glioblastoma involves removing as much of the growth as possible and preventing it from returning. Glioblastomas are a type of brain ...

This survival data along with radiographic improvements are indicative of positive treatment effects, which highlights the potential of IN8bio’s genetically modified, chemotherapy-resistant ...